These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 4297042)

  • 1. [On the histochemical properties and origin of lipofuscin in certain pathological conditions of the liver].
    Zolotarevskiĭ VB
    Arkh Patol; 1968; 30(1):21-4. PubMed ID: 4297042
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clevage of exogenous lipids in patients with chronic hepatic disease].
    Shaternikov VA; Loranskaia TI; Beiul EA; Savchuk LA
    Vopr Pitan; 1969; 28(2):11-6. PubMed ID: 5367242
    [No Abstract]   [Full Text] [Related]  

  • 3. [Distribution of biliary lipids in healthy subjects, in liver cirrhosis, fatty liver and in cholecystitis].
    Erb W; Kautzsch S
    Z Gastroenterol; 1971; 9(6):447-60. PubMed ID: 5164737
    [No Abstract]   [Full Text] [Related]  

  • 4. [Different elimination velocity of indocyanine green in liver diseases of various severity].
    Brügmann E
    Z Gesamte Inn Med; 1973 Sep; 28(17):523-6. PubMed ID: 4767186
    [No Abstract]   [Full Text] [Related]  

  • 5. [Fat metabolism and the liver].
    Gros H
    Med Klin; 1973 Aug; 68(32):1021-4. PubMed ID: 4582296
    [No Abstract]   [Full Text] [Related]  

  • 6. [Behavior of lipid classes and fatty acids in different stages of alcoholic liver disease].
    Marzo A; Ghirardi P
    Recenti Prog Med; 1971 Nov; 51(5):409-19. PubMed ID: 5172395
    [No Abstract]   [Full Text] [Related]  

  • 7. [Significance of the study of bile salts in acute and chronic liver disease].
    D'Aquino M; Della Sala S; Fazzin G; Michieletto L; Saonato F
    Quad Sclavo Diagn; 1987 Jun; 23(2):132-6. PubMed ID: 3451290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Lipid peroxidation of the liver in liver disease].
    Loginov S; Matiushin BN; Tkachev VD; Pavlova NM
    Ter Arkh; 1985; 57(2):63-7. PubMed ID: 4002141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Fatty acid composition of liver lipids in chronic hepatitis, liver cirrhosis and fatty liver].
    Mokhov VM; Bliuzdin IuA
    Vopr Med Khim; 1987; 33(3):38-42. PubMed ID: 3630012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Use of the isotope method for studying albumin metabolism in patients with chronic liver diseases].
    Vinogradov VA; Baranenkov AI
    Ter Arkh; 1974; 46(3):118-23. PubMed ID: 4828489
    [No Abstract]   [Full Text] [Related]  

  • 11. [Studies on vitamin B12 resorption in chronic liver diseases].
    Konrad H; Teichmann W; Kiencke H; Bielka B; Claus R
    Dtsch Z Verdau Stoffwechselkr; 1973; 33(4):179-83. PubMed ID: 4792418
    [No Abstract]   [Full Text] [Related]  

  • 12. [Histochemical study of the enzymes of the liver in humans with chronic hepatitis and cirrhosis].
    Zolotarevskiĭ VB; Podymova SD; Iatsyshina TA
    Arkh Patol; 1967; 29(12):62-7. PubMed ID: 4302620
    [No Abstract]   [Full Text] [Related]  

  • 13. [Cytochemical study of several enzymes in liver cells in children].
    Kolokolov AP
    Lab Delo; 1970; 5():272-5. PubMed ID: 4195102
    [No Abstract]   [Full Text] [Related]  

  • 14. [Study of the action of oxido-reductive enzymes in the liver of rats with chronic heliotrine poisoning].
    Mal'tsev VM
    Farmakol Toksikol; 1971; 34(2):228-31. PubMed ID: 4327458
    [No Abstract]   [Full Text] [Related]  

  • 15. [Biliary lipids in subjects with healthy livers, liver diseases and cholelithiasis].
    Schentke U; Jaross W; Trübsbach A
    Dtsch Z Verdau Stoffwechselkr; 1972; 32(4):303-10. PubMed ID: 4662803
    [No Abstract]   [Full Text] [Related]  

  • 16. [Lipofuscin content of the liver in various pathological conditions].
    Stepień A; Buczyński E
    Patol Pol; 1974; 25(1):81-90. PubMed ID: 4828002
    [No Abstract]   [Full Text] [Related]  

  • 17. [Improved histochemical demonstration of dehydrogenases with monotetrazolium salts].
    Seidler E; Kunde D
    Acta Histochem; 1969; 32(1):142-56. PubMed ID: 4983230
    [No Abstract]   [Full Text] [Related]  

  • 18. [Aminophenazone half life in patients with chronic liver parenchyma disorders].
    Ackermann E; Renger F; Dökert B; Walther M
    Z Gesamte Inn Med; 1972 Oct; 27(19):849-53. PubMed ID: 4647370
    [No Abstract]   [Full Text] [Related]  

  • 19. The hepatic glutathione content in liver diseases.
    Poulsen HE; Ranek L; Andreasen PB
    Scand J Clin Lab Invest; 1981 Oct; 41(6):573-6. PubMed ID: 7336124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Histochemical study of an experimental model of reversible liver cirrhosis].
    Zhuravleva MV; Rubetskoĭ LS
    Arkh Patol; 1970; 32(9):19-24. PubMed ID: 4328236
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.